-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Elevance Health, Raises Price Target to $393

Benzinga·07/16/2026 11:15:17
Listen to the news
Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $331 to $393.